NCT02244645

Brief Summary

This study may clarify a potential promising mechanism and clearest evidence to support the value of yoga as a therapeutic option for reducing chronic low back pain.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
86

participants targeted

Target at P50-P75 for not_applicable low-back-pain

Timeline
Completed

Started Dec 2013

Typical duration for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2013

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

September 16, 2014

Completed
3 days until next milestone

First Posted

Study publicly available on registry

September 19, 2014

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

September 19, 2014

Status Verified

September 1, 2014

Enrollment Period

1.9 years

First QC Date

September 16, 2014

Last Update Submit

September 18, 2014

Conditions

Keywords

Low back pain, physical therapy, yoga.

Outcome Measures

Primary Outcomes (1)

  • Back pain relief and functional life improved

    Back pain relief and functional life improved will assessed by visual analogue scale (VAS) and Roland-Morris disability questionnaire at five different times: (1)baseline data : before intervention, (2)outcome data: 3, 6, 9 and 12 week yoga exercise, right after exercise measure post-test.

    Change from baseline in back pain and life quality at 6 months

Secondary Outcomes (4)

  • Salivary cortisol concentrations decreased

    Change from baseline in salivary cortisol at 6 months

  • Heart rate variability improved

    Change from baseline in heart rate variability at 6 months

  • Immune function improved

    Change from baseline in immune function at 6 months

  • Brain-derived neurotrophic factor improved

    Change from baseline in brain-derived neurotrophic factor at 6 months

Study Arms (2)

Passive modality control group

OTHER

Passive modality control group will receive regular 40-minutes rehabilitation twice a week for 3 months.

Behavioral: passive modality

Yoga treatment group

EXPERIMENTAL

Yoga treatment group will receive regular 60-minutes yoga classes twice a week for 4 months.

Behavioral: Yoga treatment

Interventions

Passive modality control group will receive regular 40-minutes rehabilitation twice a week for 3 months.

Passive modality control group
Yoga treatmentBEHAVIORAL

Yoga treatment group will receive regular 60-minutes yoga classes twice a week for 4 months.

Yoga treatment group

Eligibility Criteria

Age20 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with idiopathic low back pain of more than 12 weeks.

You may not qualify if:

  • Current pregnancy
  • Diagnosis of ankylosing spondylitis, osteoporosis, fibromyalgia, failed back syndrome and other chronic illnesses.
  • Inability to participate yoga exercise regularly.
  • Accept steroid treatment within 3 months.
  • BMI \> 30

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Division of Core Laboratory; Chang Bing Show Chwan Memorial Hospital

Changhua County, Taiwan

RECRUITING

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kuender D. Yang, MD, PhD

    Chang Bing Show Chwan Memorial Hospital

    STUDY CHAIR
  • Shu-Hui Yeh, PhD.

    Chang Bing Show Chwan Memorial Hospital

    STUDY DIRECTOR
  • Kwan-Yu Chan, MD.

    Chang Bing Show Chwan Memorial Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Shu-Hui Yeh, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
RN, PhD, Professor

Study Record Dates

First Submitted

September 16, 2014

First Posted

September 19, 2014

Study Start

December 1, 2013

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

September 19, 2014

Record last verified: 2014-09

Locations